Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
Jing‐Quan Wang, Zhuo‐Xun Wu, Yuqi Yang, et al.
Journal of Evidence-Based Medicine (2021) Vol. 14, Iss. 3, pp. 232-256
Closed Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 76
Dysregulated Signalling Pathways Driving Anticancer Drug Resistance
Nauf Bou Antoun, Athina‐Myrto Chioni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12222-12222
Open Access | Times Cited: 46
Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes
Huai Liu, Ling Tang, Yanxian Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 33
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, N. Rajendra Prasad
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 54
Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer
Pradhapsingh Bharathiraja, Priya Yadav, Andaleeb Sajid, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101004-101004
Open Access | Times Cited: 39
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes
Hananeh Fonoudi, Mariam Jouni, Romina B. Cejas, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 38-50
Open Access | Times Cited: 15
Beta-elemene: A phytochemical with promise as a drug candidate for tumor therapy and adjuvant tumor therapy
Yewen Feng, Qingwen An, Zhengqi Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116266-116266
Open Access | Times Cited: 14
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
Y. Qin, Shisong Han, Yahan Yu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1808-1831
Closed Access | Times Cited: 14
Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide
Xiangdong Xu, Yaofeng Zheng, Linting Luo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 11
Emerging Targets in Amyotrophic lateral sclerosis (ALS): The Promise of ATP-Binding Cassette (ABC) transporter Modulation
Maneesh Mohan, Ashi Mannan, Aayush Nauriyal, et al.
Behavioural Brain Research (2024) Vol. 476, pp. 115242-115242
Closed Access | Times Cited: 10
The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics
Ahmed Hjazi, F. Nasir, Rabia Noor, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154616-154616
Closed Access | Times Cited: 17
Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
Somayeh Nazari, Fatemeh Mosaffa, Alireza Poustforoosh, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116866-116866
Closed Access | Times Cited: 8
Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles
Qingyu Lu, Wenhao Gao, Zhenzhen Chen, et al.
International Journal of Pharmaceutics (2024) Vol. 655, pp. 124028-124028
Closed Access | Times Cited: 7
NAT10‐mediated mRNA N4‐acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression
Cuicui Zhao, Xuan Sun, Jing Chen, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 10, pp. 820-829
Open Access | Times Cited: 6
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects
Luana de Fátima Alves, J. Bernadette Moore, Douglas B. Kell
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9082-9082
Open Access | Times Cited: 6
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review
Dominika Kunachowicz, Karolina Kłosowska, N. Sobczak, et al.
Nanomaterials (2024) Vol. 14, Iss. 17, pp. 1424-1424
Open Access | Times Cited: 6
In silico Analysis and Comprehensive Review of Circular-RNA Regulatory Roles in Breast Diseases; a Step-Toward non-coding RNA Precision
Nadia Μ. Hamdy, Mona G. El-Sisi, Sherine M. Ibrahim, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155651-155651
Closed Access | Times Cited: 6
Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinoma
Dawei Sun, Juan Liu, Yunfang Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
The Battlefield of Chemotherapy in Pediatric Cancers
Letao Bo, Youyou Wang, Yidong Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1963-1963
Open Access | Times Cited: 16
The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
Hailing Gao, Qingbin Cui, Jing‐Quan Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Dysregulated Signalling Pathways Driving Anti-cancer Drug Resistance
Nauf Bou Antoun, Athina‐Myrto Chioni
(2023)
Open Access | Times Cited: 15
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
Jerónimo Laiolo, Dafni G. Graikioti, Cecilia L. Barbieri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top